The Next AI Breakouts Won’t Talk Like ChatGPT

AI that chats is yesterday’s news.

This team built something more useful:
It sees your environment. It understands context. And it’s already being used 40 – 60 hours a week by 1.5M+ professionals.

Now they’re about to ship the hardware: 
Lighter than a smartphone, 2M more pixels than the Apple Vision Pro, and 1/3 the price.

Pre-IPO Shares are still just $0.66…for now.

See why some Pre-IPO investors are calling this “iPhone 2007 all over again.”

*DISCLOSURE: This is a paid advertisement for Immersed Reg A+ offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com
This Critical Mineral’s Up 122% in the Last 12 Months.

No, not gold. It’s lithium, which just hit two-year highs. What’s spurring this “white gold” rush? Critical to everything from AI to robotics to EVs, lithium demand will grow 5X by 2040. As Elon Musk put it, “It’s a license to print money.” Enter EnergyX. Their patented tech can recover 3X as much lithium as traditional methods. That’s why General Motors led a $50M investment round. Now you can join too.

Join 40k+ people as an EnergyX investor before their share price increases after 2/26.

DISCLOSURE: EnergyX’s Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at  invest.energyx.com
Beat Wall Street to the Trade

Med-X is preparing for a Nasdaq listing (MXRX)-but by the time the bell rings, it may be too late. Already generating $6.4M in revenue, its Nature-Cide line is sold e-commerce giants like Amazon, Walmart, and Kroger and is expanding into 41+ markets.

As regulators, consumers, and climate pressure push the $17B pest control industry natural, Med-X is positioned to lead. Right now, shares are just $4.00 through a limited Reg A+ offering.

Don’t wait for Wall Street’s headlines-[review the Med-X opportunity now].

Disclosures: This is a paid advertisement for Med-X’s Regulation A+ Offering. Please read the offering circular at invest.medx-rx.com.
Top Wall Street analysts recommend these dividend stocks for consistent income

As stock markets continue to be volatile, investors looking for a stable income stream can bolster their portfolios with the addition of attractive dividend stocks. Selecting good dividend stocks from a vast universe of companies can be challenging.

Privacy Policy | Advertiser DisclosureDISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don’t trade with money you can’t afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.

Stockguru LLC (dba InvestingDistrict), 2563 cherry hill ln, Hermitage, PA 16148, United StatesYou may unsubscribe or change your contact details at any time.